期刊文献+

溃疡汤联合西药三联疗法治疗幽门螺杆菌相关性十二指肠溃疡70例临床观察 被引量:16

Clinical Observation on the Effect of Kuiyang Decoction plus Triad-therapy of Western Medicine on 70 Cases of Helicobacter Pylori Related Duodenal Ulcer
下载PDF
导出
摘要 目的探讨溃疡汤与西药三联疗法相结合治疗幽门螺杆菌(Hp)相关性十二指肠溃疡患者疗效及其对Hp的根除作用。方法将140例患者随机分为对照组70例,采用西药三联疗法,口服奥美拉唑、羟氨苄青霉素、甲硝唑,均每日2次,连服1周,然后单服奥美拉唑,连服3周;治疗组70例,口服溃疡汤4周,同时口服上述西药,服法同对照组。两组分别于治疗前后检测Hp,并对临床疗效作对比分析。结果胃镜下疗效、Hp清除率、症状改善及治疗后1年复发率,治疗组均优于对照组(P<0.05)。结论溃疡汤合西药三联疗法治疗Hp阳性十二指肠溃疡能够提高Hp根除率,具有较好的疗效。 Objective To study the effect and eradication of Kuiyang Decoction(decoction for ulcer) plus triad-therapy of western medicine on helicobacter pylori(Hp) positive duodenal ulcer.Methods The 140 cases were randomly divided into two groups.The control group,70 cases,was treated by standard triad-therapy:omeprazole,amoxicillin and metronidazole per os for one week in succession,then only omeprazole,20mg each time,twice a day,3 weeks in succession.The treatment group,70 cases,was treated by Kuiyang Decoction per os,one dose each day,for 4 weeks in succession in addition to taking the above-mentioned western medicines in the same way as the control group.Before and after treatment both groups were given the Hp test for comparing the therapeutic effect.Results The treatment group was better than the control group in the effect under gastroscope,Hp eradication rate,symptom improvement,and one-year recurrent rate(P〈0.05).Conclusion The combination of Kuiyang Decoction plus triad-therapy of western medicine for the treatment of Hp positive duodenal ulcer is remarkable in improving eradicative rate of Hp.
出处 《中医杂志》 CSCD 北大核心 2008年第6期520-522,共3页 Journal of Traditional Chinese Medicine
关键词 溃疡汤 十二指肠溃疡 三联疗法 幽门螺杆菌 Kuiyang Decoction(decoction for ulcer) Duodenal ulcer Triad-therapy Helicobacter pylori(Hp)
  • 相关文献

参考文献7

二级参考文献43

  • 1徐州,周德端,段国勋,王瑛,梁凤凌,汪俊林,杨晓华.中药对幽门螺杆菌抑杀作用的实验研究[J].中国医药学报,1993,8(5):25-26. 被引量:174
  • 2胡伏莲,黄志烈,王菊梅,贾博琦,刘新光,谢鹏雁.幽门螺杆菌的根除及其在十二指肠溃疡愈合和复发中的作用[J].中华消化杂志,1996,16(2):106-107. 被引量:109
  • 3吴志伟,李建平,何金海,江志红.大尺度大气环流异常与长江中下游夏季长周期旱涝急转[J].科学通报,2006,51(14):1717-1724. 被引量:85
  • 4李益农 陆星华.消化内镜学[M].北京:科学技术出版社,1996.213.
  • 5Malfertheiner P, Mégraud F, O Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther,2002,16:167-180.
  • 6Mégraud F, Hazell S, Glupczynski Y. Antibiotic susceptibility and resistance. In: Mobley HLT, Mendz GL, Hazell SL, eds.Helicobacter pylori: Physiology and Genetics. Washington DC:ASM Press,2001. 511-530.
  • 7Mégraud F. Helicobacter pylori and macrolides. In: Schonfeld W, Kirst HA, eds. Macrolide antibiotics. Berlin: Birkhauser,2002. 243-260.
  • 8Gisbert JP, Calvet X, Bujanda L, et al. Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.Helicobacter, 2003,8: 90-94.
  • 9Masconi G, Parente F, Russo A, et al. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol, 2001,96: 359-366.
  • 10Baena JM, Lopez C, Hidalgo A, et al. Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week. Eur J Gastroenterol Hepatol, 2002,14: 291-296.

共引文献833

同被引文献146

引证文献16

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部